Skip to main content
NACFC 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestreamed Session
Livestreamed Session
Ticketed Session
Ticketed Session
Recorded Session
Recorded Session
Session includes invitee/speaker with CF. Others with CF encouraged to participate virtually.
Session includes invitee/speaker with CF. Others with CF encouraged to participate virtually.

NTR
Workshop

W37--Leading the Pack: Nutrition Research

Saturday, September 28, 2024
10:15 AM - 12:15 PM ET
Location:206 AB

Recorded Session

The Leading the Pack: Nutrition Research session will cover the impact of CFTR modulators on clinical outcomes including gastrointestinal symptoms, pancreatic function, intestinal inflammation and lipid profiles. The session will also examine the relationship between PPI use and fat absorption. Finally, the session will explore the opportunities for dietitians to be involved in clinical research and partner with CF research teams. Speakers for this session will be discussing results from several large, multi-center research studies including PROMISE, BEGIN, and GOAL.

Learning Objectives:

  • Review the impact of CFTR modulators and PPI medications on clinical outcomes, including GI symptoms, pancreatic function, intestinal inflammation, lipid profiles, and fat absorption.
  • Describe the impact of large, multi-center, nutrition-related studies on the future clinical trial design and clinical care guidance.
  • Discuss how clinical dietitians can partner with clinical research teams.

Presentations:

  • 10:15 AM - 12:15 PM ET
    W37.1- Elexacaftor/tezacaftor/ivacaftor does not improve pancreatic function in people with CF >12 years old: Report of PROMISE GI at 30 months

    Speaker: Sarah Jane Schwarzenberg, MD (she/her/hers) – MHealth Fairview Masonic Children's Hospital

  • 10:15 AM - 12:15 PM ET
    W37.2- Evaluating serum lipid changes after Ivacaftor initiation in the GOAL study

    Speaker: Scott H. Donaldson, MD (he/him/his) – University of North Carolina at Chapel Hill

  • 10:15 AM - 12:15 PM ET
    W37.3- Changes in fecal pancreatic elastase in children with CF with 6 months of highly-effective modulator therapy: Results from the BEGIN study

    Speaker: Angshita Dutta, MS – University of Washington

  • 10:15 AM - 12:15 PM ET
    W37.4- Proton Pump Inhibitor Therapy and PERT: Pilot Study of Impact on Fat Absorption

    Speaker: Virginia Stallings (she/her/hers) – Children's Hospital of Philadelphia

  • 10:15 AM - 12:15 PM ET
    W37.5- Elevating the Role of the RD in Research

    Speaker: Jessica A. Alvarez, PhD, RD (she/her/hers) – Emory University